Citi Downgrades NGM Biopharmaceuticals (NGM) to Neutral
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Form SC 13D/A NGM BIOPHARMACEUTICALS Filed by: COLUMN GROUP L P
February 26, 2024 5:16 PM EST
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
... MoreForm SC14D9C NGM BIOPHARMACEUTICALS Filed by: NGM BIOPHARMACEUTICALS INC
February 26, 2024 5:12 PM EST
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
... MoreForm 8-K NGM BIOPHARMACEUTICALS For: Feb 25
February 26, 2024 5:02 PM ESTNGM BIOPHARMACEUTICALS INC false 0001426332 0001426332... More
Form SC TO-C NGM BIOPHARMACEUTICALS Filed by: COLUMN GROUP L P
February 26, 2024 4:56 PM EST
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.... More



